Order Article Reprints

Izhar M, Al Gharyani M, Kattaa AH, Cardona JJ, Jain RP, Shaghaghian E, Hori YS, Lam FC, Abu Reesh D, Emrich SC, et al. Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases. Pharmaceutics. 2025; 17(7):899. https://doi.org/10.3390/pharmaceutics17070899

Izhar, Muhammad, Mohamed Al Gharyani, Ahed H. Kattaa, Juan J. Cardona, Ruchit P. Jain, Elaheh Shaghaghian, Yusuke S. Hori, Fred C. Lam, Deyaaldeen Abu Reesh, Sara C. Emrich, and et al. 2025. "Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases" Pharmaceutics 17, no. 7: 899. https://doi.org/10.3390/pharmaceutics17070899

Izhar, M., Al Gharyani, M., Kattaa, A. H., Cardona, J. J., Jain, R. P., Shaghaghian, E., Hori, Y. S., Lam, F. C., Abu Reesh, D., Emrich, S. C., Ustrzynski, L., Tayag, A., Lesniak, M. S., Chang, S. D., & Park, D. J. (2025). Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases. Pharmaceutics, 17(7), 899. https://doi.org/10.3390/pharmaceutics17070899